ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2305

Influence Of Disease Activity On The Physical Activity Of Rheumatoid Arthritis Patients

Vanesa Hernández-Hernández1, Ivan Ferraz-Amaro2, Esmeralda Delgado-Frías1, Sagrario Bustabad-Reyes1 and Federico Diaz-Gonzalez3, 1Rheumatology, Hospital Universitario de Canarias, La Laguna, Spain, 2Rheumatology, Servicio de Reumatologia. Hospital Universitario de Canarias, Tenerife, Spain, 3Rheumatology, Servicio de Reumatologia.Hospital Universitario de Canarias, La Laguna, Spain

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Disease Activity, functional status, physical activity and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis-Clinical Aspects III: Outcome Measures, Socioeconomy, Screening, Biomarkers in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: It is generally assumed that rheumatoid arthritis (RA) patients tend to exercise less than what is currently recommended. However, there is little data on the level of daily PA in RA patients vs. to healthy controls, using objective procedures, such as accelerometry. Moreover, there remain two important unanswered questions concerning PA vis-à-vis RA: 1) Do patients who are sufficiently physically active suffer from less severe disease? and viceversa, 2) Does disease activity influence PA in RA patients?. With regard to the former, there is considerably more evidence in favor of prescribing PA for RA patients than there is against. However, there is currently no evidence that decisively answers the latter.

The purposes of this study were to compare PA in a group of RA patients versus healthy controls through both objective (triaxial accelerometry) and subjective (International Physical Activity Questionnaire- IPAQ) methods, and to explore the impact of disease levels on PA in these patients. We also sought to determine the potential role of PA assessment as a measure of RA disease activity.

Methods:

A group of 50 RA patients and 50 age-and sex-matched healthy controls were included in this cross-sectional study. PA was assessed by accelerometry and with the IPAQ. We performed multiple regression analysis not only to compare PA between groups, but also to explore the relation between RA features, including disease activity and cardiovascular risk parameters, and PA. In a randomized group of 30 RA patients a test/re-test study was carried out in order to determine the correlation between variations in disease activity and PA.

Results:

The number of minutes of moderate and vigorous activity/day, as evaluated by accelerometry and adjusted for sex, age, work activity was significantly lower in RA patients than in healthy controls (23±16 vs 33±27 min/day, p=0.02). In RA patients, accelerometry and IPAQ demonstrated concordance to a moderate degree (quadratic weighed Kappa index of 0.27 [0.06-0.48], p=0.02). HAQ negatively correlated with both IPAQ and accelerometry data (beta coef. -1623 (-2742- -503) MET/min/week, p=0.00; beta coef -43 (-81- -6.46) counts/min, p 0.02). DAS28-CRP was also inversely related with IPAQ. Framinghan score and metabolic syndrome were inversely associated with PA in RA patients. Interestingly, variations in PA, as measured by accelerometry, inversely correlated with RA disease activity (r:-0.42, p= 0.02), particularly in the patient group that exhibited changes in DAS28 consistent with an RA flare or improvement.

Conclusion:

In RA patients, accelerometry is a reliable technique to evaluate PA. Not only showed that RA patients spend less time doing moderate and vigorous PA than healthy controls, but also PA, as assessed by accelerometry, was sensitive to any changes in disease activity.


Disclosure:

V. Hernández-Hernández,
None;

I. Ferraz-Amaro,
None;

E. Delgado-Frías,
None;

S. Bustabad-Reyes,
None;

F. Diaz-Gonzalez,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/influence-of-disease-activity-on-the-physical-activity-of-rheumatoid-arthritis-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology